Long-term effects of radioiodine treatment on salivary gland function in adult survivors of pediatric differentiated thyroid carcinoma

T Selvakumar, M Nies, MSK Hesselink… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Pediatric differentiated thyroid cancer (DTC) is a rare disease. Initial treatment of DTC
consists of a total or near-total thyroidectomy and 131I therapy. Previous studies on adults …

Effects of radioiodine treatment on salivary gland function in patients with differentiated thyroid carcinoma: a prospective study

ENK Hesselink, AH Brouwers, JR de Jong… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Complaints of a dry mouth (xerostomia) and sialoadenitis are frequent side effects of
radioiodine treatment in differentiated thyroid cancer (DTC) patients. However, detailed …

[PDF][PDF] Changes in salivary gland function following radioiodine therapy of thyroid diseases: A comparison of high-dose therapy for thyroid cancer and low-dose …

EA FARD, B Fallahi, M Karimi, D Beiki, M Saghari… - 2015 - sid.ir
Introduction: High-dose radioactive iodine therapy in differentiated thyroid cancer (DTC) may
adversely affect the salivary gland function. This study is aimed to evaluate the effect of …

Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer

JP Almeida, AE Sanabria, ENP Lima… - Head & neck, 2011 - Wiley Online Library
Background. The purpose of this study was to assess the late side effects of radioiodine
therapy (RIT) on salivary gland function. One hundred eighty two patients were evaluated …

Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up

J Wu, H Feng, W Ouyang, Y Sun, P Chen… - Nuclear medicine …, 2015 - journals.lww.com
Objectives Radioiodine therapy is a common adjunct to thyroidectomy in papillary thyroid
cancer treatment. However, a variety of associated adverse effects have been reported. In …

Semi-quantitative assessment of salivary gland function in patients with differentiated thyroid carcinoma after radioiodine-131 treatment.

AF Esfahani, B Fallahi, R Olamaie… - Hellenic Journal of …, 2004 - europepmc.org
Sialadenitis and xerostomia are well-known side effects of high-dose radioactive iodine
((131) Iota) treatment in patients with differentiated thyroid carcinoma (DTC). This study was …

Significance of Salivary Gland Radioiodine Retention on Post-ablation 131I Scintigraphy as a Predictor of Salivary Gland Dysfunction in Patients with Differentiated …

KS Jo, YS An, SJ Lee, EY Soh, J Lee, YS Chung… - Nuclear medicine and …, 2014 - Springer
Purpose We investigated whether 131 I whole-body scintigraphy could predict functional
changes in salivary glands after radioiodine therapy. Methods We evaluated 90 patients …

Dysfunction of the salivary and lacrimal glands after radioiodine therapy for thyroid cancer: Results of the START study after 6-months of follow-up

C Baudin, A Bressand, C Buffet, F Menegaux, M Soret… - Thyroid, 2023 - liebertpub.com
Background: Understanding of changes in salivary and lacrimal gland functions after
radioactive iodine therapy (131I-therapy) remains limited, and, to date, no studies have …

Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer

D Albano, F Bertagna, MB Panarotto… - Pediatric blood & …, 2017 - Wiley Online Library
Abstract Background Radioiodine‐131 (I131) therapy for differentiated thyroid cancer (DTC)
is generally a safe and effective treatment, but it has some potential side effects, which have …

Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer

JL Marti, KS Jain, LGT Morris - Thyroid, 2015 - liebertpub.com
Introduction: The long-term sequelae of radioactive iodine (RAI) for differentiated thyroid
cancer (DTC) in pediatric and young adult patients are not well-defined. Epidemiologic …